| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 8888888 |
Internal/system code - not a standard HCPCS code |
2,898 |
1,586 |
$2.48M |
| 36415 |
Collection of venous blood by venipuncture |
5,748 |
5,089 |
$402K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
9,699 |
8,309 |
$295K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,096 |
1,913 |
$144K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,089 |
1,027 |
$110K |
| 80053 |
Comprehensive metabolic panel |
10,652 |
8,755 |
$102K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,853 |
2,476 |
$101K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,462 |
1,397 |
$93K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,637 |
5,036 |
$87K |
| 87400 |
|
2,242 |
1,156 |
$48K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,161 |
1,832 |
$48K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,281 |
2,956 |
$44K |
| 81001 |
|
6,621 |
5,614 |
$37K |
| 70450 |
Computed tomography, head or brain; without contrast material |
734 |
676 |
$32K |
| 71046 |
Radiologic examination, chest; 2 views |
1,724 |
1,562 |
$29K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
415 |
381 |
$29K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,088 |
939 |
$27K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
72 |
64 |
$22K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,352 |
2,409 |
$19K |
| 87430 |
|
1,384 |
1,305 |
$19K |
| 87510 |
|
117 |
116 |
$18K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,319 |
2,087 |
$15K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,298 |
1,943 |
$15K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
965 |
894 |
$13K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,184 |
2,682 |
$13K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
155 |
141 |
$12K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
11,589 |
9,331 |
$11K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
139 |
121 |
$11K |
| 82962 |
|
953 |
711 |
$10K |
| 87077 |
|
1,067 |
960 |
$10K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
196 |
187 |
$10K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,142 |
2,763 |
$9K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
759 |
601 |
$8K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
738 |
660 |
$8K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,133 |
3,608 |
$7K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,706 |
1,594 |
$6K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
169 |
114 |
$6K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,103 |
2,653 |
$6K |
| 71045 |
Radiologic examination, chest; single view |
970 |
879 |
$6K |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
81 |
80 |
$6K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
41 |
39 |
$5K |
| 90715 |
|
30 |
28 |
$5K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,482 |
1,324 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
525 |
461 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
289 |
275 |
$4K |
| 87070 |
|
144 |
130 |
$3K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,261 |
2,844 |
$3K |
| 81025 |
|
749 |
658 |
$3K |
| 73130 |
|
58 |
50 |
$3K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
995 |
910 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,896 |
3,129 |
$3K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
41 |
39 |
$3K |
| 84439 |
|
841 |
807 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,257 |
1,054 |
$2K |
| 80061 |
Lipid panel |
411 |
399 |
$2K |
| 87420 |
|
539 |
493 |
$2K |
| 84703 |
|
1,750 |
1,582 |
$2K |
| 73564 |
|
27 |
25 |
$2K |
| 73110 |
|
30 |
25 |
$1K |
| 73030 |
|
57 |
50 |
$1K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
627 |
607 |
$1K |
| 73630 |
|
50 |
46 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,536 |
2,366 |
$1K |
| 73610 |
|
27 |
24 |
$1K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
63 |
62 |
$1K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
14 |
14 |
$1K |
| 80055 |
|
26 |
25 |
$941.99 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
948 |
893 |
$798.39 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
806 |
718 |
$708.62 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
179 |
175 |
$643.61 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
14 |
13 |
$622.34 |
| 88150 |
|
80 |
79 |
$615.98 |
| 76801 |
|
14 |
12 |
$570.45 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
593 |
543 |
$493.58 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
267 |
242 |
$443.64 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
418 |
356 |
$360.69 |
| 84702 |
|
149 |
103 |
$360.42 |
| 82950 |
|
24 |
24 |
$359.30 |
| 86900 |
|
179 |
150 |
$356.74 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,867 |
1,727 |
$348.06 |
| 87081 |
|
28 |
28 |
$330.64 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
966 |
894 |
$300.55 |
| 86140 |
|
591 |
539 |
$263.65 |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
365 |
336 |
$223.65 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
98 |
94 |
$151.98 |
| 85379 |
|
807 |
752 |
$147.53 |
| 86803 |
|
16 |
16 |
$133.13 |
| 87653 |
|
27 |
26 |
$113.33 |
| 86850 |
|
38 |
30 |
$108.29 |
| 83735 |
|
1,770 |
1,544 |
$98.00 |
| 82550 |
|
1,122 |
1,018 |
$84.53 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
270 |
249 |
$74.96 |
| 84484 |
|
2,429 |
1,753 |
$74.46 |
| 83880 |
|
514 |
473 |
$58.27 |
| 83690 |
|
2,092 |
1,800 |
$56.97 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
521 |
500 |
$48.76 |
| 85610 |
|
1,490 |
1,303 |
$36.55 |
| 85027 |
|
739 |
688 |
$29.91 |
| 87186 |
|
815 |
727 |
$17.87 |
| 85730 |
|
764 |
699 |
$16.21 |
| 87040 |
|
766 |
389 |
$15.02 |
| 83605 |
|
572 |
488 |
$11.14 |
| 84100 |
|
533 |
479 |
$10.64 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
65 |
62 |
$8.92 |
| 87660 |
|
117 |
116 |
$0.00 |
| 84145 |
|
255 |
226 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
13 |
12 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
14 |
14 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
28 |
24 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
24 |
24 |
$0.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
16 |
14 |
$0.00 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
484 |
346 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
108 |
104 |
$0.00 |
| G0378 |
Hospital observation service, per hour |
908 |
768 |
$0.00 |
| A9270 |
Non-covered item or service |
14 |
12 |
$0.00 |
| 96376 |
|
796 |
625 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
171 |
167 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
263 |
242 |
$0.00 |
| 85652 |
|
97 |
85 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
250 |
205 |
$0.00 |
| 87480 |
|
117 |
116 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
139 |
133 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
12 |
12 |
$0.00 |
| 86901 |
|
179 |
150 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
42 |
38 |
$0.00 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
30 |
27 |
$0.00 |
| 94760 |
|
70 |
64 |
$0.00 |
| 87205 |
|
104 |
95 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
57 |
56 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
15 |
14 |
$0.00 |
| J3411 |
Injection, thiamine hcl, 100 mg |
29 |
25 |
$0.00 |
| 74019 |
|
12 |
12 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
32 |
25 |
$0.00 |